Literature DB >> 27133410

Comment on Analyses and Conclusions of "Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study".

Raj Narendran1, W Gordon Frankle1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27133410     DOI: 10.1176/appi.ajp.2016.15111417

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  18 in total

1.  Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28.

Authors:  K Collste; P Plavén-Sigray; H Fatouros-Bergman; P Victorsson; M Schain; A Forsberg; N Amini; S Aeinehband; S Erhardt; C Halldin; L Flyckt; L Farde; S Cervenka
Journal:  Mol Psychiatry       Date:  2017-02-14       Impact factor: 15.992

2.  In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [11C](R)-PK11195 positron emission tomography study.

Authors:  S E Holmes; R Hinz; R J Drake; C J Gregory; S Conen; J C Matthews; J M Anton-Rodriguez; A Gerhard; P S Talbot
Journal:  Mol Psychiatry       Date:  2016-10-04       Impact factor: 15.992

3.  Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.

Authors:  T Notter; J M Coughlin; T Gschwind; U Weber-Stadlbauer; Y Wang; M Kassiou; A C Vernon; D Benke; M G Pomper; A Sawa; U Meyer
Journal:  Mol Psychiatry       Date:  2017-01-17       Impact factor: 15.992

Review 4.  Sifting through the surfeit of neuroinflammation tracers.

Authors:  Paul Cumming; Bjorn Burgher; Omkar Patkar; Michael Breakspear; Neil Vasdev; Paul Thomas; Guo-Jun Liu; Richard Banati
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-19       Impact factor: 6.200

5.  PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of Neuroinflammation.

Authors:  Tamara Berdyyeva; Chunfang Xia; Natalie Taylor; Yingbo He; Gang Chen; Chaofeng Huang; Wei Zhang; Hartmuth Kolb; Michael Letavic; Anindya Bhattacharya; Anna Katrin Szardenings
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

6.  Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA.

Authors:  Sina Hafizi; Tania Da Silva; Cory Gerritsen; Michael Kiang; R Michael Bagby; Ivana Prce; Alan A Wilson; Sylvain Houle; Pablo M Rusjan; Romina Mizrahi
Journal:  Neuropsychopharmacology       Date:  2017-06-12       Impact factor: 7.853

7.  TSPO expression and brain structure in the psychosis spectrum.

Authors:  Sina Hafizi; Elisa Guma; Alex Koppel; Tania Da Silva; Michael Kiang; Sylvain Houle; Alan A Wilson; Pablo M Rusjan; M Mallar Chakravarty; Romina Mizrahi
Journal:  Brain Behav Immun       Date:  2018-06-12       Impact factor: 7.217

Review 8.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

9.  Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis.

Authors:  Shima Shakory; Jeremy J Watts; Sina Hafizi; Tania Da Silva; Saad Khan; Michael Kiang; R Michael Bagby; Sofia Chavez; Romina Mizrahi
Journal:  Neuropsychopharmacology       Date:  2018-07-28       Impact factor: 7.853

10.  Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study.

Authors:  Sina Hafizi; Tania Da Silva; Jeffrey H Meyer; Michael Kiang; Sylvain Houle; Gary Remington; Ivana Prce; Alan A Wilson; Pablo M Rusjan; Napapon Sailasuta; Romina Mizrahi
Journal:  Neuropsychopharmacology       Date:  2018-04-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.